Fig. 8 | Scientific Reports

Fig. 8

From: Multiomics analysis reveals the involvement of NET1 in tumour immune regulation and malignant progression

Fig. 8

Correlations of NET1 expression with the immunotherapy response and drug sensitivity. (A) Differences in NET1 expression between the immune treatment group and the control group. (B) Differences in NET1 expression between the cytokine treatment group and the control group. (C) Ability of NET1 to serve as a biomarker compared with other markers in different immune therapy cohorts. (D) The GDSC and CTRP (E) databases were used to predict drugs that are influenced by NET1 expression levels. Abbreviations: Neg, negative correlation; Pos, positive correlation; *P < 0.05, **P < 0.01, and ***P < 0.001.

Back to article page